177
+ Investors.
Track Smart Money conviction in GRFS.
See who's accumulating, reducing, or initiating positions.
Fetching live quote...
Current
Price
--USD
Analyst
Target
--(0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
3Q ▲
Buyers last Q
51%
Smart Money Signals — GRFS
Based on 175 hedge funds · latest filing: 2025 Q4 · updated quarterly
📈
Buying streak — 3 quarters in a row
last 6Q
For 3 consecutive quarters, more hedge funds added GRFS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️
At the ownership peak (100% of max)
100% of all-time peak
175 hedge funds hold GRFS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀
Fast accumulation — +21% more funds vs a year ago
fund count last 6Q
+30 new funds entered over the past year (+21% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡
Slight buying edge — 51% buying
89 buying86 selling
Last quarter: 89 funds bought or added vs 86 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️
Fewer new buyers each quarter (-11 vs last Q)
new funds entering per quarter
Funds opening this position for the first time: 20 → 22 → 41 → 30. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒
57% of holders stayed for 2+ years
■ 57% conviction (2yr+)■ 17% medium■ 26% new
100 out of 175 hedge funds have held GRFS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎
Buying through price weakness — shares +2%, value -95%
Value
-95%
Shares
+2%
Last quarter: funds added +2% more shares while total portfolio value only changed -95%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀
Acceleration phase — new buyers rushing in
22 → 20 → 22 → 41 → 30 new funds/Q
New funds entering each quarter: 20 → 22 → 41 → 30. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️
Deep conviction — 62% of holders stayed 2+ years
■ 62% veterans■ 10% 1-2yr■ 28% new
Of 177 current holders: 110 (62%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆
Elite ownership — 40% AUM from top-100 funds
40% from top-100 AUM funds
28 of 175 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in GRFS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.1
out of 10
Moderate Exit Risk
Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.
Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data.
"Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings.
They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.
Institutional Sentiment Summary — GRFS
In 2025 Q4, 89 hedge funds were net buyers of GRFS (30 opened a new position, 59 added to an existing one),
while 86 reduced or exited (58 trimmed, 28 sold completely) —
a 51% buyer ratio, indicating a slight buying edge.
This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal.
40% of total institutional value in GRFS is held by top-100 AUM funds, reflecting elite-tier ownership quality.
Net fund flow last quarter: +2 funds (more new holders than closures).
Total institutional holders: 175.
Hedge Fund Ownership: GRFS
How many hedge funds hold GRFS — quarterly history vs. share price
Quarterly hedge fund ownership of GRFS vs. share price
Market Analysis: GRFS
Analyst Price Targets
Avg. Price Target
--
Based on -- analysts offering 12-month
price targets for GRFS.
Average target -- —
high --,
low --.
Analyst Recommendations
■ Strong Buy■ Buy■ Hold■ Sell■ Str. Sell
Stock Performance
Real-time
MTD
YTD
1 Year
3 Years
—
vs SPY
Company Profile: GRFS
HealthcareDrug Manufacturers - General
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GRFS.
Verified SEC 13F-HR filings.
What does the Smart Money Trend signal show for GRFS?
Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added GRFS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
What is the institutional breadth score for GRFS?
Slight buying edge — 51% buying: Last quarter: 89 funds bought or added vs 86 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
What is the fund quality score for GRFS holders?
Elite ownership — 40% AUM from top-100 funds: 28 of 175 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in GRFS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
How long have hedge funds held GRFS?
57% of holders stayed for 2+ years: 100 out of 175 hedge funds have held GRFS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
Where does this institutional ownership data come from?
All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.
Disclaimer:
The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.
👋
Welcome to 13Foresight!
We track 13F filings from thousands of hedge funds and alert you when your followed funds file new positions.